Qiagen (QGEN) Reports In-Line Q4 EPS, provides outlook

Qiagen (NYSE: QGEN) reported Q4 EPS of $0.62, in-line with the analyst estimate of $0.62. Revenue for the quarter came in at $540 million versus the consensus estimate of $528.47 million.

2026 outlook: Net sales growth of at least 5% CER with growth pillars expected to contribute about $1.64 billion CER (~+9% CER) and adj. diluted EPS of at least $2.50 CER

For earnings history and earnings-related data on Qiagen (QGEN) click here.

You May Also Be Interested In

• Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
• Cintas beats estimates but stock edges lower
• Crude Inventory Rose 2.97 Million Barrels Last Week - EIA